The latest biotech news

News and Trends 15 Jan 2021

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal focused on the skin microbiome, receiving up to €185M from GlaxoSmithKline (GSK) as they explore a CRISPR-based treatment for acne. Acne is a condition that troubles the majority of adolescents and often persists into adulthood. […]

January 15, 2021 - 4 minutesmins - By Kostas Vavitsas

mRNA DNA race Covid 19 vaccine BioNTech Pfizer

News and Trends 22 Dec 2020

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its kind to be approved by the EMA. The EMA has granted conditional approval to Comirnaty, a vaccine against Covid-19 developed by BioNTech and Pfizer. The approval comes weeks after the UK became the first country in the world to approve […]

December 22, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 21 Dec 2020

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field with a drug that puts brakes on inflammation in the brain. Last week, AB Science reported successful results from a phase IIb/III clinical trial testing its drug masitinib in patients with mild to moderate symptoms of Alzheimer’s. Although the company […]

December 21, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 17 Dec 2020

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed the achievements of many innovative treatments for blood conditions, including gene and cell therapies. A sweeping new wave of Covid-19 infections that is forcing new lockdowns across the northern hemisphere is already reshaping the biotech […]

December 17, 2020 - 6 minutesmins - By Victor Kotsev

Cultured meat Europe cellular agriculture

News and Trends 14 Dec 2020

Will Europe Follow Singapore in Approving Cultured Meat?

Singapore is the first country to grant approval to meat grown from animal cells, known as cultured meat. Will European countries follow suit? Eat Just is a San Francisco-based company that sells plant-based alternatives to eggs and other animal products. The firm made headlines last week when it got regulatory approval to market cultured chicken […]

December 14, 2020 - 5 minutesmins - By Kostas Vavitsas

Covid 19 manufacturing vaccine therapies antibody

News and Trends 9 Dec 2020

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Companies developing vaccines, drugs, and diagnostics for Covid-19 are being forced to scale up manufacturing at high speed in order to meet the enormous demand. There has been an unprecedented amount of research carried out over the last year to develop vaccines, drugs, and diagnostic tests to combat the Covid-19 pandemic. Before Canada gave the […]

December 9, 2020 - 5 minutesmins - By Helen Albert

tourette syndrome treatment noema pharma

News and Trends 7 Dec 2020

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

In spite of recent failures of clinical trials from others in the field, Swiss company Noema Pharma is gearing up to develop better treatments for the neurological condition Tourette’s syndrome. Noema Pharma will use a recent €49M Series A round to bankroll the phase I development of a candidate for Tourette’s syndrome along with the […]

December 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 4 Dec 2020

EU Launches Pharma Strategy, Raising Both Hopes and Questions

The public’s response has been cautious after the European Union unveiled a pharmaceutical strategy last week designed to spur domestic innovation and the production of affordable, state-of-the-art therapies. Amid a boom in biotech funding driven by the Covid-19 pandemic, the European Commission (EC) is scrambling to bring its sometimes fragmented pharma regulatory framework up to […]

December 4, 2020 - 6 minutesmins - By Victor Kotsev

gene therapy blood disorder hemophilia b

News and Trends 27 Nov 2020

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer to the market as Dutch developer uniQure became the first to release interim phase III results last week. Hemophilia is an inherited disease caused by mutations to genes encoding blood clotting proteins, resulting in uncontrollable bleeds. In severe cases of […]

November 27, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 26 Nov 2020

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70% efficacy in phase III interim data. While less effective on paper, it could prove cheaper and easier to distribute than its most advanced competitors. Scientists and politicians heartily received the announcement of promising interim clinical trial results from the Covid-19 […]

November 26, 2020 - 4 minutesmins - By Kostas Vavitsas

cancer treatments immuno oncology companies

News and Trends 23 Nov 2020

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

The newly founded SynOx has become the latest startup to attack solid tumors via their ‘comfort zone’, known as the tumor microenvironment. SynOx was spun out of the UK firm Celleron Therapeutics last week with a huge Series A round of €37M. The fledgling company is developing an antibody drug that Celleron licensed from Roche […]

November 23, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Nov 2020

Breakthroughs in Decentralized Testing Could Contain Covid-19

Hospital facilities in Europe are being pushed to their limits as the Covid-19 pandemic continues into winter. Coronavirus testing that doesn’t require a central lab is now arriving on the scene, and it could be the solution to effectively monitor and contain the disease. Despite the recent announcements of promising phase III data on Covid-19 […]

November 20, 2020 - 4 minutesmins - By Kostas Vavitsas

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation

Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference

Will Europe Follow Singapore in Approving Cultured Meat?

The Manufacturing Challenge to Meet Covid-19 Vaccine Demands

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

EU Launches Pharma Strategy, Raising Both Hopes and Questions

uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

Breakthroughs in Decentralized Testing Could Contain Covid-19

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!